All Stories

  1. Mesenchymal stromal cell extracellular vesicles rescue mitochondrial dysfunction and improve barrier integrity in clinically relevant models of ARDS
  2. Therapeutic targeting of metabolic alterations in acute respiratory distress syndrome
  3. The Necrobiology of Mesenchymal Stromal Cells Affects Therapeutic Efficacy
  4. Hypercapnic acidosis induces mitochondrial dysfunction and impairs the ability of mesenchymal stem cells to promote distal lung epithelial repair
  5. Concise Review: Intercellular Communication Via Organelle Transfer in the Biology and Therapeutic Applications of Stem Cells
  6. The TLR4-PAR1 Axis Regulates Bone Marrow Mesenchymal Stromal Cell Survival and Therapeutic Capacity in Experimental Bacterial Pneumonia
  7. Mesenchymal Stromal Cells Modulate Macrophages in Clinically Relevant Lung Injury Models by Extracellular Vesicle Mitochondrial Transfer
  8. Aspirin reduces lipopolysaccharide-induced pulmonary inflammation in human models of ARDS
  9. Analysis of Mitochondrial Transfer in Direct Co-cultures of Human Monocyte-derived Macrophages (MDM) and Mesenchymal Stem Cells (MSC)
  10. Mitochondrial Transfer via Tunneling Nanotubes is an Important Mechanism by Which Mesenchymal Stem Cells Enhance Macrophage Phagocytosis in the In Vitro and In Vivo Models of ARDS
  11. S63 Human Mesenchymal Stromal Cell (hMSC) regulation of human macrophages inin vitromodels of the Acute Respiratory Distress Syndrome (ARDS)
  12. T3 Mitochondrial transfer is an important mechanism by which Mesenchymal Stromal Cells (MSC) facilitate macrophage phagocytosis in thein vitroandin vivomodels of Acute Respiratory Distress Syndrome (ARDS)
  13. Interaction of arenicin-1 with C1q protein
  14. Mesenchymal stromal cells for treatment of the acute respiratory distress syndrome: The beginning of the story
  15. Expression pattern of arenicins—the antimicrobial peptides of polychaete Arenicola marina
  16. T1 Aspirin reduces pulmonary inflammation in an inhaled lipopolysaccharide model of acute respiratory distress syndrome (ARDS) in healthy volunteers and in a human ex vivo lung perfusion model of ARDS
  17. Correction
  18. Therapeutic Effects of Human Mesenchymal Stem Cells inEx VivoHuman Lungs Injured with Live Bacteria
  19. MSCs for Treatment of Acute Lung Injury
  20. Human mesenchymal stem cells reduce mortality and bacteremia in gram-negative sepsis in mice in part by enhancing the phagocytic activity of blood monocytes
  21. Mouse Mesenchymal Stem Cells Enhance The Innate Respiratory Immune Response To Bacterial Infection By Secretion Of Lipocalin 2 /NGAL
  22. Mesenchymal stem cells enhance survival and bacterial clearance in murineEscherichia colipneumonia
  23. Concise Review: Mesenchymal Stem Cells for Acute Lung Injury: Role of Paracrine Soluble Factors
  24. Allogeneic Human Mesenchymal Stem Cells Inhibit Bacterial Growth And Restore Normal Alveolar Fluid Transport In An Ex Vivo Perfused Human Lung Injured By Live E. Coli
  25. Human Mesenchymal Stem Cells Exert Antimicrobial Activity In Vitro And In Vivo In Part Through The Secretion Of The Antimicrobial Peptide LL-37
  26. Mesenchymal Stem Cells Therapy Reduces Bacteremia And Enhances The Phagocytic Activity Of Circulating Monocytes In A Mouse Model Of Gram Negative Sepsis
  27. Antibacterial Effect of Human Mesenchymal Stem Cells Is Mediated in Part from Secretion of the Antimicrobial Peptide LL-37
  28. Mesenchymal Stem Cells Augment The Innate Respiratory Immune Response To Bacterial Infection And Possess Intrinsic Antimicrobial Properties
  29. Bone Marrow-Derived Cells Participate in Stromal Remodeling of the Lung Following Acute Bacterial Pneumonia in Mice
  30. Structure and mode of action of the antimicrobial peptide arenicin
  31. Peroxiredoxin V Contributes to Antioxidant Defense of Lung Epithelial Cells
  32. Purification and primary structure of two isoforms of arenicin, a novel antimicrobial peptide from marine polychaetaArenicola marina